Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study.
Brain Behav Immun
; 62: 41-45, 2017 May.
Article
in En
| MEDLINE
| ID: mdl-27871802
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
3_ND
Database:
MEDLINE
Main subject:
Schizophrenia
/
Candida albicans
/
Probiotics
/
Gastrointestinal Tract
/
Gastrointestinal Microbiome
/
Antibodies, Bacterial
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Brain Behav Immun
Year:
2017
Document type:
Article